Submission Details
| 510(k) Number | K131015 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 11, 2013 |
| Decision Date | October 08, 2013 |
| Days to Decision | 180 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K131015 is an FDA 510(k) clearance for the BIODESIGN ONLAY DURAL GRAFT OR BIODESIGN DURAPLASTY GRAFT, a Dura Substitute (Class II — Special Controls, product code GXQ), submitted by Cook Biotech, Inc. (West Lafayetta, US). The FDA issued a Cleared decision on October 8, 2013, 180 days after receiving the submission on April 11, 2013. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5910.
| 510(k) Number | K131015 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 11, 2013 |
| Decision Date | October 08, 2013 |
| Days to Decision | 180 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GXQ — Dura Substitute |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5910 |